A UK-based clinical-stage CNS biotech leveraging its proprietary NETSseq platform and machine learning to discover novel brain cell targets and advance differentiated therapies for Parkinson's disease and beyond.
A UK-based clinical-stage CNS biotech leveraging its proprietary NETSseq platform and machine learning to discover novel brain cell targets and advance differentiated therapies for Parkinson's disease and beyond.
